Tsumura & Co. (TYO:4540)

Market Cap	257.21B
Revenue (ttm)	181.09B
Net Income (ttm)	32.43B
Shares Out	74.71M
EPS (ttm)	427.14
PE Ratio	8.06
Forward PE	10.12
Dividend	136.00 (4.02%)
Ex-Dividend Date	Mar 28, 2025

Volume	639,500
Average Volume	563,080
Open	3,430.00
Previous Close	3,387.00
Day's Range	3,413.00 - 3,445.00
52-Week Range	3,306.00 - 5,138.00
Beta	-0.01
RSI	47.69
Earnings Date	Aug 5, 2025

About Tsumura & Co.

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,138
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In 2024, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.